CRN-09682

N/A

Report date: 2025/08/20 20:01:27
NMEFirst In Class

Base Information

Drug NameCRN-09682
Drug Alias NameCRN-09682CRN09682
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 2 agonistsTubulin polymerisation inhibitors
TargetsSomatostatin receptor 2Tubulin
Therapy Area/IndicationsCarcinoma, NeuroendocrineNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, NeuroendocrineNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A